ÂÜÀòÂÒÂ×

Esther Collado, PhD, is currently serving as the Regional Scientific Director at Intellia Therapeutics, Inc., focusing on rare diseases and CRISPR-based gene editing therapeutics. With extensive experience in international medical affairs, previous roles include Senior International Medical Science Liaison in Haemato-Oncology at Syros Pharmaceuticals, and MSL positions at Nordic Nanovector ASA, Celgene, and Boehringer Ingelheim. Esther has a strong academic background with a PhD in Developmental Biology from the University of Leeds and has completed multiple master's degrees in Clinical Trial Monitoring, Reproductive Biology, and Human Assisted Reproductive Technologies.